Abstract
Milk is a good source of nutrition but is also a source of allergenic proteins such as α-lactalbumin, β-lactoglobulin (BLG), casein, and immunoglobulins. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas technology has the potential to edit any gene, including milk allergens. Previously, CRISPR/Cas has been successfully employed in dairy cows and goats, but buffaloes remain unexplored for any milk trait. In this study, we utilized the CRISPR/Cas9 system to edit the major milk allergen BLG gene in buffaloes. First, the editing efficiency of designed sgRNAs was tested in fibroblast cells using the T7E assay and Sanger sequencing. The most effective sgRNA was selected to generate clonal lines of BLG-edited cells. Analysis of 15 single-cell clones, through TA cloning and Sanger sequencing, revealed that 7 clones exhibited bi-allelic (−/−) heterozygous, bi-allelic (−/−) homozygous, and mono-allelic (−/+) disruptions in BLG. Bioinformatics prediction analysis confirmed that non-multiple-of-3 edited nucleotide cell clones have frame shifts and early truncation of BLG protein, while multiple-of-3 edited nucleotides resulted in slightly disoriented protein structures. Somatic cell nuclear transfer (SCNT) method was used to produce blastocyst-stage embryos that have similar developmental rates and quality with wild-type embryos. This study demonstrated the successful bi-allelic editing (−/−) of BLG in buffalo cells through CRISPR/Cas, followed by the production of BLG-edited blastocyst stage embryos using SCNT. With CRISPR and SCNT methods described herein, our long-term goal is to generate gene-edited buffaloes with BLG-free milk.
Similar content being viewed by others
Introduction
Domesticated buffaloes play a significant role in dairy industry. Globally, buffaloes contribute 16% of fresh whole milk, while cattle contribute to the remainder 84%. In Southeast Asia, the role of buffaloes is even more pronounced, accounting for 35.45% of fresh whole milk, while cattle contribute 64.54%1. Milk, a prominent nutritious food, holds significant importance in daily diets. However, some proteins such as α-lactalbumin, β-lactoglobulin (BLG), casein, and immunoglobulins act as allergens to susceptible individuals2. Among these proteins, BLG is a major allergen in the milk of farm animals, including buffaloes3. Traditional efforts to reduce milk allergenicity involve processing methods like pasteurization or ultra-high temperature treatment to denature milk proteins2. However, these methods are costly, impact nutritional value, and could potentially maintain allergenicity by creating new epitopes4. Alternatively, recently developed gene editing (GE) techniques provide a precise and targeted approach to modify gene(s) responsible for milk allergenicity without compromising milk qualities5.
In farm animals, the combinations of GE and assisted reproductive technologies (ARTs) have been used for the production of targeted gene-edited animals. Among the livestock, cattle and buffaloes have long generation intervals and are monotocous, i.e., yield one offspring per calving. In these species, somatic cell nuclear transfer (SCNT) is the preferred ART for producing GE animals. Over the last decade, SCNT has been efficiently used to produce several gene-edited farm animals6. In buffalo, our group produced more than 20 cloned buffaloes using optimized SCNT method7. However, very limited attempts have been made to produce gene-edited cloned embryos in buffaloes and no live calf was produced yet. Recently, our group reported the successful production of MSTN-gene edited cloned embryos of buffalo8.
For modifying milk compositions, previous studies highligthed the production of BLG edited cells, embryos, and animals (cows and goats) using GE technologies9,10,11,12. However, before this study, no attempt was made in buffalo to edit BLG. To address this gap, we utilized the CRISPR/Cas system and SCNT method to generate BLG-edited single cell clones and their use to produce cloned embryos. This study provides evidence of the utility GE in buffaloes and offer promising prospects for producing BLG knockout buffaloes in the future.
Results
Determination of the BLG editing efficiency in buffalo fibroblasts
We designed three sgRNAs to target the buffalo BLG (Fig. 1A), and assessed their editing efficiency in fibroblast cells. The T7E assay results have additional bands with expected sizes indicated successful editing of BLG. sgRNA2 exhibited 45.39% and sgRNA3 exhibited 43.64% editing rates (Fig. 1B). Conversely, sgRNA1 exhibited negative T7E assay results, which indicated its inefficacy to induce editing events at the BLG target site (Fig. 1B and supplementary Fig. 2). Further scrutiny of the transfected cells with sgRNA2 was conducted through Sanger sequencing and subsequent the Tracking of Indels by Decomposition (TIDE) and the Inference of CRISPR Edits (ICE) analyses (Fig. 1C and D). TIDE analysis identified 51.8% editing efficiency, and ICE analysis identified 50% editing efficiency. Based on these analyses, sgRNA2 was selected for subsequent experiments.
Establishment of single cell clones of BLG-edited fibroblasts and their analysis
The generation of single cell clones is a crucial step in the production of CRISPR-based edited cloned embryos and animals by SCNT method. In this study, we established 15 single cell clones, and noticed that some of the colonies have high level of vacuolation and abnormal morphology (Fig. 2A–C). To confirm the BLG editing in these established clones, PCR-based screening was performed. Gel electrophoresis of the PCR products revealed that three colonies, denoted as C1, C4, and C10, exhibited two bands, indicative of large deletions at the target site (Fig. 2D). Subsequent Sanger sequencing confirmed editing events in seven single-cell clones (C1, C2, C4, C8, C10, C11, and C13). To detect allele specific information, we employed TA cloning and Sanger sequencing analysis of these seven single cell clones. These seven clones exhibited various types of editing, including bi-allelic (−/−) heterozygous, bi-allelic (−/−) homozygous and mono-allelic (−/+) gene editing, each involving distinct nucleotide deletions and insertions (Fig. 3). Off-target (OT) effects are a significant concern in CRISPR/Cas9 applications. We screened five potential OT sites across three single-cell clones (C2, C10, and C13). Sanger sequencing revealed no detectable OT effects in our BLG-edited cell clones (Supplementary Fig. 2).
Bioinformatic prediction of BLG-edited mutations
We also aimed to analyze, validate, translate, and predict the 3D structure of edited nucleotide sequences of BLG. ExPASy translated the BLG amino acid sequences, and their ORFs aligned with the wild-type BLG protein sequence to identify fate of gene editing (Fig. 4A). AlphaFold2 was employed for 3D protein structure prediction, considering insertion, deletion, and substitution events. AlphaFold2 predicted distorted structures for sequences with non multiple of 3 deletion or insertion events (C1A1, C2A1, C2A2, C4A1, C10A2, C11A1, and C13A2), causing coding frame shifts and truncation. In contrast, sequences with multiple of 3 events (C1A2, C8A1, C10A1, and C13A1) resulted in complete but slightly disoriented proteins due to amino acid deletions (Fig. 4B).
Generation of cloned embryos from BLG-edited fibroblasts
We used 4 different BLG-edited cell clones as donor cells for the generation of cloned embryos through handmade cloning (HMC) method of SCNT (Fig. 5A). In each HMC experiment involved the utilization of two different BLG-edited cell clones alongside wild-type fibroblasts. The in vitro developmental competences of embryos were recorded at day 8 (Table 1). To assess the health of the produced blastocysts, we performed the TUNEL assay (Fig. 5B). The results indicated that there were no significant differences in terms of total cell count and apoptotic index between edited donor cells-derived cloned blastocysts and wild-type cloned blastocysts (Fig. 5C and D).
Discussion
Milk is a prominent nutritional source for humans, yet certain individuals, particularly infants, may experience allergies to milk and its derivatives3. Notably, the BLG, a protein found in ruminant milk, has been identified as an allergen, however, this protein is absent in human milk15. With advancements in GE technologies, several researchers have attempted to edit the BLG that aims to eliminate this allergenic component from ruminant milk9,10,11,12,16,17,18. BLG-free cow milk exhibited diminished allergenicity in Balb/c mice, with reduced allergic responses such as rectal temperature drop and allergen-specific IgE production11. Also, IgE binding from cow milk allergy patients to BLG-free milk significantly decreased in comparison to control milk. Thus, GE approach holds promise for addressing milk allergies and enhancing the overall safety and tolerability of dairy products for individuals having BLG sensitivities. Based on these findings and importance of buffalo milk globally, we edited BLG to produce embryos via SCNT. This study offers a pathway for generating buffaloes yielding BLG-free milk.
Three sgRNAs were designed for CRISPR-based editing of the BLG gene, with sgRNA2 showing favorable outcomes, as demonstrated by T7E and Sanger sequencing results. Considering the variability in sgRNA efficacy, it's prudent to assess multiple sgRNAs for target genes19. Electroporation was chosen as the transfection method due to its speed, simplicity, and scalability20. In this study, the overall editing rate was 46.7%, which aligns with rates in farm animals. For instance, Bajwa et al.21 achieved 33% editing rates, Dua et al.8 achieved 25% editing rates, and Su et al.22 achieved 72% editing rates in buffalo fibroblasts, Wang et al.23 achieved 21% editing rates in pig fibroblasts, and Ishino et al.24 achieved 11.3% editing rates in cattle fibroblasts. The efficiency of gene editing is control by several factors such as GC contents of PAM, nucleotides sequence at the sgRNA spacer, secondary structure of sgRNA, chromatin state, and transcriptional stage of targeted gene25. Therefore, understanding and engineering the CRISPR/Cas9 system is crucial. Despite advancements, achieving maximum genome-editing efficiency with minimal off-target effects remains challenging. To assess potential off-target mutations, we Sanger sequenced five potential off-target sites in three cell clones (C2, C10, and C13). The sequencing results revealed absence of off-target modifications in all three clones. Thus, this study yields precise BLG-edited single-cell clones for SCNT applications in buffalo.
Establishing single-cell clonal populations is challenging and tedious task. Common methods like cloning rings and limiting dilution have drawbacks such as mixing of cells26. We opted for the manual pick-up method, in which manually transferring single cells into each well of a 96-well plate under microscopic control. This approach was previously used to establish single cell clonal population from electroporated buffalo cells8,21. We established 15 single-cell clones, of which 4 clones displaying bi-allelic (−/−) and 3 clones displaying mono-allelic (−/+) editing. We also observed that extended culture condition led to vacuolation and abnormal morphology in both edited and non-edited clones24. Addressing this, we propose supplementing the culture medium with growth factors like ITS, EGF, and FGF to stimulate fibroblast proliferation.
We conducted a comprehensive analysis of nucleotide sequences of seven BLG-edited cell clones. Our findings revealed distinct structural outcomes for edited sequences that influenced by the nature of deletion or insertion events. This aligns with the frame preserving nature of multiples of three insertions or deletions that allow the maintenance of the correct reading frame during translation27. The similar predictions have been made by other researchers28. Based on these prediction data, bi-allelic cell clone C2 can be most preferred for the production of live BLG-edited buffaloes through SCNT. As cryopreservation allows the long term storage of cells, we cryopreserved all these cell clones for future applications.
Application of GE for buffalo embryo production presents challenges, especially the choice between embryo production methods such as zygote microinjection and SCNT. Zygote microinjection often yields mosaic embryos and low gene editing rates, thus, posing difficulties in generating homozygous animals in long gestation period animals, such as buffalo29,30,31,32. In contrast, SCNT employs pre-screened gene edited cells as donors, holds promise for producing GE animals with desired genetic traits without the issue of mosaicism31,34,35. Our previous work utilized the HMC method for SCNT as it eliminates the need for expensive micromanipulation equipment and skilled personnel, making it an attractive option for GE applications in buffalo8. In this study, blastocyst rates were comparable among wild type embryos (43.80%) and edited clones such as bi-allelic (C-2) at 41.33 and (C-13) at 38.63%, and mono-allelic (C-11) at 42.60%. These findings imply that BLG editing does not significantly affect early embryonic development, and the results are agreeing with observations in other farm animal species9,11,18. However, mono-allelic clone C-10 exhibited lower blastocyst production (28.88%). The low blastocyst production rates of C10 could be due to a high level of vacuolation and abnormal cell morphology. It has been reported that vacuolation level and abnormal morphology of donor cells significantly affected the production of blastocysts8,33,36. The quality of embryos plays a pivotal role in determining the success of pregnancy establishment of in-vitro produced embryos37,38. The TUNEL assay was performed to assess the health of BLG-edited cloned embryos. There were no significant differences in total cell count and apoptotic index between BLG-edited and wild type cloned blastocysts. The TUNEL assay results indicated that there are no significant differences in total cell count and apoptotic index between BLG-edited and wild-type cloned blastocysts. However, further experiments are needed to determine the in-vivo developmental competence of these edited embryos and their suitability for live gene-edited buffalo production.
Conclusion
We demonstrated the successful bi-allelic (−/−) editing of the BLG gene in buffalo cells through CRISPR and production of BLG-edited blastocyst stage embryos by SCNT. To our knowledge, this is the first report that demonstrated the production of BLG-edited embryos in buffalo. With the CRISPR system described herein, our long-term goal is to produce gene-edited buffaloes with BLG free milk traits to address milk allergy concerns.
Methods
Ethics statements
All experiments were performed according to the ethical standards of the institute. Animal procedures including biopsy collection were approved by the Institute Animal Ethics Committee, ICAR-National Dairy Research Institute, Karnal, India. The study is reported in accordance with ARRIVE guidelines, and approved by Institutional Biosafety Committee (IBSC).
CRISPR single guide RNA (sgRNA) design and transfection of buffalo fibroblasts
To edit BLG in buffalo, we used CHOPCHOP software (https://chopchop.cbu.uib.no/) with BLG gene ID, default NGG PAM, and 20 nucleotide sgRNA length settings to design three sgRNAs targeting exon 2 and 3 of the BLG. The designed sgRNA candidates were in-vitro transcribed using precision gRNA synthesis kit (Thermo Scientific#A29377) as per the manufacturer’s instructions, and then co-transfected with Cas9 protein (Thermo Scientific#A36498) into newborn female buffalo fibroblasts that were established as per our lab protocol13. The cells at passage 2 were transfected using the Amaxa nucleofector reagents (Lonza, Basel, Switzerland), according to program EN150 as per the manufacturer’s guidelines. Transfected cells were cultured for 72 h, and then, collected for genomic DNA extraction and generation of single cell clonal lines. The T7E1 assay and Sanger sequencing were performed to verify status of targeted BLG gene editing.
Detection of editing rates
The genomic DNA from transfected cells was extracted utilizing the Wizard genomic DNA purification kit, (Promega#A1125) as per the manufacturer’s instructions. The BLG primers (for exon 2, F- TGCCCCTCAAATTTTCCCCA and R-AAAGCCCTGGATAAGCAGCC; and for exon 3, F-CTGGCCCTCAGTTCATCCT and R-AGCAAAGAGAGCTCGGGTGT) were designed using PRIMER3 software (http://bioinfo.ut.ee/primer3-0.4.0/) and homology checked through nblast against nucleotide database of NCBI. The target sequence was subsequently amplified through polymerase chain reaction (PCR) under the following conditions: initial denaturation at 94 °C for 5 min, followed by 40 cycles at 94 °C for 20 s, 60 °C for 30 s, 72 °C for 35 s, and a final extension at 72 °C for 5 min. The PCR products from each sample underwent assessment using the T7E1 assay to detect editing in the BLG gene. Following denaturation and annealing of PCR products in NEB buffer 2 using a thermocycler, the hybridized PCR products underwent digestion with T7 endonuclease 1 (NEB#M0302L) for a duration of 20 min at 37 °C. The digested products were then subjected to 2% agarose gel electrophoresis. The gel images were analysed using the Gel Analyzer 19.1 software (www.gelanalyzer.com). The editing rate was determined by employing the formula: efficiency = [(sum of cleaved band intensities/(sum of cleaved and parental band intensities)] × 100. For TIDE and ICE analysis, PCR products were submitted for Sanger sequencing and resulted files were uploaded to the TIDE web tool (http://tide.nki.nl) and the ICE web tool (https://ice.synthego.com) for analysis. Both algorithms provided the percentage of insertions and deletions (indels).
Establishment of single cell clones and their genotype analysis
After 72 h of transfection, cells were trypsinized and the cell pellet was suspended in culture medium. The resuspended cells were then dispersed at low density in 3 mL of culture medium in a 35-mm culture dish. Single cells were manually picked using a fine-pulled glass capillary under optical control with a stereo zoom microscope and transferred into individual wells of a 96-well plate (one cell per well). The culture medium was supplemented with 10 ng/mL epidermal growth factor (Gibco#PHG0311) to enhance proliferation, and the EGF-supplemented culture media were refreshed every fifth day. Regular examination of cell clones was conducted using an inverted microscope, and morphology images were captured. Subsequently, cells from each clone were expanded, analyzed, and cryopreserved for future use. In the established single cell clones, BLG editing was assessed by analyzing targeted BLG-specific PCR products. These PCR products from each single cell clone were ligated into the pJet1.2/blunt TA cloning vector using the Clone JET PCR cloning kit (Thermo Scientific#K1232). Following this, the cloned PCR products were transformed into E.coli cells, and plasmids were isolated from 8 to 10 E. coli colonies using a geneJET plasmid miniprep kit (Thermo Scientific#K0503). The isolated plasmids underwent the Sanger sequencing, and the obtained data were analyzed to determine the actual editing genotypes.
Off-target analysis
We computationally predicted potential off-targets (OTs) of sgRNA2 using Cas-Offinder (http://www.rgenome.net/cas-offinder/), aligning with the buffalo genome assembly (NDDB_SH_1). Five OTs containing NGG PAM were selected (supplementary table 1 and 2). Off-target sites were amplified via conventional PCR, followed by Sanger sequencing. Analysis were done on three single cell clones, namely C2, C10, and C13, to detect any potential off-target effects.
Protein structure prediction from edited sequences
Firstly, we retrieved the nucleotide sequence (Accession no. AJ005429.1) and the corresponding amino acid sequence (Accession no. CAA06532.1) of the wild type BLG from the NCBI database. We targeted exon 2 of the BLG, and edited DNA sequences were placed into the corresponding wild type nucleotide sequences to generate the complete coding sequences. Subsequently, we utilized the ExPASy translation tool (https://web.expasy.org/translate/) to predict the open reading frames (ORFs) of the edited nucleotide sequences. To identify suitable ORF templates for further analysis, we performed the BLASTp, and compared the edited ORFs and the wild-type BLG protein (P02755, available at the UniProt database). This step aimed to select the appropriate templates for 3D structure prediction. Multiple alignments of the predicted amino acid sequences and the wild-type BLG were carried out using T-coffee (https://www.ebi.ac.uk/Tools/msa/tcoffee/). The protein structure prediction relies on the alignment between the wild type BLG sequence and edited ORF templates. For the actual 3D structure of the predicted amino acid sequences, we employed AlphaFold2, a highly efficient deep learning and artificial intelligence based tool (https://alphafold.ebi.ac.uk/). The resulting predicted structures were visualized using the PyMOL molecular graphics system, Version 2.0, by Schrӧdinger LLC (https://pymol.org/2/).
Production of cloned embryos
The handmade cloning (HMC) method, which was reported by us14, was employed for the production of BLG-edited cloned embryos. Briefly, buffalo ovaries were collected from a local abattoir and transported to the laboratory in normal saline within 4–6 h, and oocytes were harvested. In-vitro matured oocytes were denuded and subjected to zona pellucida removal, followed by manual bisection of protrusion cone-bearing oocytes. For nuclear transfer, donor cells, comprising BLG-edited fibroblasts, were paired with enucleated cytoplasts using phytohemagglutinin. The wild type fibroblasts were used as control. The resulting couplets underwent a single step electrofusion to form the triplets composed of a demi-oocyte, somatic cell, and another demi-oocyte. After 4 h incubation, the reconstructed oocytes were activated with calcimycin A23187, followed by 6-dimethylaminopurine treatment. The activated embryos were cultured in Research Vitro Cleave medium (K-RVCL-50, Cook®, Australia) supplemented with 1% fatty acid-free BSA in 4-well dishes, with 15–20 embryos per well. The dishes were covered with mineral oil and kept undisturbed in a CO2 incubator for 8 days. On day 8, blastocyst production rates were evaluated as indicators of in-vitro developmental competence.
Evaluation of embryo quality
For the evaluation of embryo quality, day 8 blastocysts were assessed for the total cell count and apoptosis index through TUNEL staining. Blastocysts were washed thrice with Dulbecco's phosphate-buffered saline (DPBS) containing 0.3% polyvinyl alcohol (PVA) in a 4-well dish and fixed in 4% paraformaldehyde for 1 h at 37 °C. After additional washes, the blastocysts were stored at 4 °C until staining. Permeabilization was achieved by incubating blastocysts with 0.5% triton X-100 for 40 min, followed by incubation with FITC-conjugated dUTP and terminal deoxynucleotidyltransferase (TdT) for 90 min at 37 °C in the dark. Subsequently, the embryos were treated with nuclear staining solution (10 µg/mL Hoechst 33342 and 50 µg/mL RNase in DPBS + 0.3% PVA) for 25 min at 37 °C. Stained blastocysts were mounted on glass slides, and images were captured using both UV and green filters to examine nuclei and apoptosis sites, respectively. Digital images obtained from an inverted fluorescence microscope were used for analysis. The apoptotic index for each blastocyst was calculated as follows: Apoptotic index of blastocyst = (number of TUNEL-positive nuclei/total number of nuclei in blastocyst) × 100.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism 5 software. The datasets underwent analysis through one-way analysis of variance (ANOVA), followed by the Tukey test for post hoc comparisons. Percentage values were subjected to arcsine transformation before analysis. Statistical significance was considered at a threshold of P < 0.05. The results are presented as mean ± standard error of the mean (SEM).
Data availability
The sequencing dataset of BLG target region generated during the current study is available in the NCBI-Gen Bank repository (Accession numbers: OQ851625.1).
Change history
10 September 2024
A Correction to this paper has been published: https://doi.org/10.1038/s41598-024-72295-1
References
Food and Agriculture Organization (FAO). Agricultural data (2023, accessed 10 Jan 2024). http://apps.fao.org.
Monaci, L., Tregoat, V., van Hengel, A. J. & Anklam, E. Milk allergens, their characteristics and their detection in food: A review. Eur. Food Res. Technol. 223, 149–179. https://doi.org/10.1007/s00217-005-0178-8 (2006).
Barbiroli, A., Iametti, S. & Bonomi, F. Beta-lactoglobulin as a model food protein: How to promote, prevent, and exploit its unfolding processes. Molecules 27(3), 1131. https://doi.org/10.3390/molecules27031131 (2022).
Sathe, S. K., Teuber, S. S. & Roux, K. H. Effects of food processing on the stability of food allergens. Biotechnol. Adv. 23(6), 423–429. https://doi.org/10.1002/mnfr.200800194 (2005).
Brackett, N. F., Pomes, A. & Chapman, M. D. New frontiers: Precise editing of allergen genes using CRISPR. Front. Allergy 2, 821107. https://doi.org/10.3389/falgy.2021.821107 (2022).
Galli, C. & Lazzari, G. 25th Anniversary of cloning by somatic-cell nuclear transfer: Current applications of SCNT in advanced breeding and genome editing in livestock. Reproduction 162(1), F23-32. https://doi.org/10.1530/rep-21-0006 (2021).
Selokar, N. L. et al. Somatic cell nuclear transfer and its applications in buffalo (Bubalus bubalis). In Biotechnological Applications in Buffalo Research (eds Chauhan, M. S. & Selokar, N. L.) 439–457 (Springer, 2022).
Dua, S. et al. Production of MSTN gene-edited embryos of buffalo using the CRISPR/Cas9 system and SCNT. Cell Reprogram. 25(3), 121–127. https://doi.org/10.1089/cell.2023.0003 (2023).
Ni, W. et al. Efficient gene knockout in goats using CRISPR/Cas9 system. PloS one 9(9), e106718. https://doi.org/10.1371/journal.pone.0106718 (2014).
Zhou, W. et al. Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9. PloS one 12(10), e0186056. https://doi.org/10.1371/journal.pone.0186056 (2017).
Sun, Z. et al. Production of hypoallergenic milk from DNA-free beta-lactoglobulin (BLG) gene knockout cow using zinc-finger nucleases mRNA. Sci. Rep. 8(1), 15430. https://doi.org/10.1038/s41598-018-32024-x (2018).
Wei, J. et al. Cattle with a precise, zygote-mediated deletion safely eliminate the major milk allergen beta-lactoglobulin. Sci. Rep. 8(1), 7661. https://doi.org/10.1038/s41598-018-25654-8 (2018).
Selokar, N. L. et al. Establishment of a somatic cell bank for Indian buffalo breeds and assessing the suitability of the cryopreserved cells for somatic cell nuclear transfer. Cell Reprogram. 20(3), 157–163. https://doi.org/10.1089/cell.2017.0066 (2018).
Selokar, N. L. et al. Effect of post-fusion holding time, orientation and position of somatic cell-cytoplasts during electrofusion on the development of handmade cloned embryos in buffalo (Bubalus bubalis). Theriogenology 78(4), 930–936. https://doi.org/10.1016/j.theriogenology.2012.03.018 (2012).
Sawyer, L. β-Lactoglobulin and glycodelin: Two sides of the same coin?. Front. Physiol. 12, 678080. https://doi.org/10.3389/fphys.2021.678080 (2021).
Cui, C. et al. Gene targeting by TALEN-induced homologous recombination in goats directs production of β-lactoglobulin-free, high-human lactoferrin milk. Sci. Rep. 5(1), 10482. https://doi.org/10.1038/srep10482 (2015).
Luo, Y. et al. Generation of TALE nickase-mediated gene-targeted cows expressing human serum albumin in mammary glands. Sci. Rep. 6(1), 20657. https://doi.org/10.1038/srep20657 (2016).
Zhu, H. et al. Generation of β-lactoglobulin-modified transgenic goats by homologous recombination. FEBS J. 283(24), 4600–4613. https://doi.org/10.1111/febs.13950 (2016).
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8(11), 2281–2308. https://doi.org/10.1038/nprot.2013.143 (2013).
Kim, T. K. & Eberwine, J. H. Mammalian cell transfection: The present and the future. Anal. Bioanal. Chem. 397(8), 3173–3178. https://doi.org/10.1007/s00216-010-3821-6 (2010).
Bajwa, K. K. et al. Electroporation-based CRISPR gene editing in adult buffalo fibroblast cells. Anim. Biotechnol. 34(9), 5055–5066. https://doi.org/10.1080/10495398.2023.2271030 (2023).
Su, X. et al. Efficient genome editing in cultured cells and embryos of Debao pig and swamp buffalo using the CRISPR/Cas9 system. In Vitro Cell Dev. Biol. Anim. 54, 375–383. https://doi.org/10.1007/s11626-018-0236-8 (2018).
Wang, K. et al. Efficient generation of myostatin mutations in pigs using the CRISPR/Cas9 system. Sci. Rep. 5(1), 16623. https://doi.org/10.1038/srep16623 (2015).
Ishino, T. et al. Establishment of protocol for preparation of gene-edited bovine ear-derived fibroblasts for somatic cell nuclear transplantation. Biomed. Res. 39(2), 95–104. https://doi.org/10.2220/biomedres.39.95 (2018).
Jung, W. J., Park, S. J., Cha, S. & Kim, K. Factors affecting the cleavage efficiency of the CRISPR-Cas9 system. Anim. Cells Syst. (Seoul) 28(1), 75–83. https://doi.org/10.1080/19768354.2024.2322054 (2024).
Gross, A. et al. Technologies for single-cell isolation. Int. J. Mol. Sci. 16(8), 16897–16919. https://doi.org/10.3390/ijms160816897 (2015).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2 (2021).
Porto-Neto, L. R. et al. Convergent evolution of slick coat in cattle through truncation mutations in the prolactin receptor. Front. Genet. 9, 57. https://doi.org/10.3389/fgene.2018.00057 (2018).
Crispo, M. et al. Efficient generation of myostatin knock-out sheep using CRISPR/Cas9 technology and microinjection into zygotes. PloS one 10(8), e0136690. https://doi.org/10.1371/journal.pone.0136690 (2015).
Bevacqua, R. J. et al. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system. Theriogenology 86(8), 1886–1896. https://doi.org/10.1016/j.theriogenology.2016.06.010 (2016).
Zhang, X. et al. Disruption of the sheep BMPR-IB gene by CRISPR/Cas9 in in vitro-produced embryos. Theriogenology 91, 163–172. https://doi.org/10.1016/j.theriogenology.2016.10.025 (2017).
Punetha, M. et al. Optimising electroporation condition for CRISPR/CAS-mediated knockout in zona-intact buffalo zygotes. Animals 14(1), 134. https://doi.org/10.3390/ani14010134 (2023).
Carlson, D. F. et al. Production of hornless dairy cattle from genome-edited cell lines. Nat. Biotechnol. 34(5), 479–481. https://doi.org/10.1038/nbt.3560 (2016).
Yuan, M. et al. HMEJ-based safe-harbor genome editing enables efficient generation of cattle with increased resistance to tuberculosis. J. Biol. Chem. 296, 100497. https://doi.org/10.1016/j.jbc.2021.100497 (2021).
Workman, A. M. et al. First gene-edited calf with reduced susceptibility to a major viral pathogen. PNAS Nexus 2(5), pgad125. https://doi.org/10.1093/pnasnexus/pgad125 (2023).
Moro, L. N. et al. Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer. Sci. Rep. 10(1), 15587. https://doi.org/10.1038/s41598-020-72040-4 (2020).
Erdem, H. et al. Effect of embryo quality and developmental stages on pregnancy rate during fresh embryo transfer in beef heifers. Trop. Anim. Health Prod. 52(5), 2541–2547. https://doi.org/10.1007/s11250-020-02287-6 (2020).
Demetrio, D. G. B. et al. How can we improve embryo production and pregnancy outcomes of Holstein embryos produced in vitro? (12 years of practical results at a California dairy farm). Anim. Reprod. 17(3), e20200053. https://doi.org/10.1590/1984-3143-AR2020-0053 (2020).
Acknowledgements
This work was supported by a grant from the Bill & Melinda Gates Foundation, USA (Grant No. BMGF/INV-044234), and partially by a grant from the Indian Council of Agricultural Research, New Delhi, India (Grant No. NASF/GTR-8025).
Author information
Authors and Affiliations
Contributions
AT and PS participated in transfection experiments, single cell clone generation, cloned embryo production, and data recording. DG conducted PCR, TA cloning, and Sanger sequencing. GT and MKS were responsible for maintaining single cell clones, producing cloned embryos, and recording embryo production data. CU performed bioinformatics analysis of edited sequences. SM established primary somatic cells and cryopreserved edited cells. SD analyzed Sanger sequencing data and troubleshooted experiments. BT supervised the project, reviewed and edited the manuscript, and supported funding. NLS conceptualized the study, designed sgRNAs, produced cloned embryos, curated data, wrote the manuscript, and acquired funding. All authors have reviewed and agreed to publish this version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this Article was revised: The original version of this Article contained an error in the Acknowledgements section. Full information regarding the correction made can be found in the correction for this article.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tara, A., Singh, P., Gautam, D. et al. CRISPR-mediated editing of β-lactoglobulin (BLG) gene in buffalo. Sci Rep 14, 14822 (2024). https://doi.org/10.1038/s41598-024-65359-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-65359-9
- Springer Nature Limited